BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12891909)

  • 21. Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland.
    Carsin AE; Drummond FJ; Black A; van Leeuwen PJ; Sharp L; Murray LJ; Connolly D; Egevad L; Boniol M; Autier P; Comber H; Gavin A
    Cancer Causes Control; 2010 Sep; 21(9):1523-31. PubMed ID: 20514514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of serum prostate-specific antigen-alpha1-antichymotrypsin complex for diagnosis of prostate cancer in Japanese cases.
    Kuriyama M; Abrahamsson PA; Imai K; Akimoto S; Deguchi N; Shichiri Y; Sugiyama Y; Niwa T; Inoue T
    Scand J Urol Nephrol; 2001 Feb; 35(1):5-10. PubMed ID: 11291689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.
    Mokete M; Shackley DC; Betts CD; O'Flynn KJ; Clarke NW
    BJU Int; 2006 Feb; 97(2):266-9. PubMed ID: 16430626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Luján M; Páez A; Pascual C; Angulo J; Miravalles E; Berenguer A
    Eur Urol; 2006 Dec; 50(6):1234-40; discussion 1239-40. PubMed ID: 16704893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer screening in the Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur J Cancer; 2000 Jun; 36(10):1322-35. PubMed ID: 10882875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
    Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE
    J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer epidemiology in a rural area of North Western Greece.
    Grivas N; Hastazeris K; Kafarakis V; Tsimaris I; Xousianitis Z; Makatsori A; Raptis P; Aspiotis S; Ioachim E; Ntemou A; Kitsiou E; Malamou-Mitsi V; Sofikitis N; Kordela V; Papandreou C; Agnantis NJ; Stavropoulos NE
    Asian Pac J Cancer Prev; 2012; 13(3):999-1002. PubMed ID: 22631687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of increasing detection in the rising incidence of prostate cancer.
    Potosky AL; Miller BA; Albertsen PC; Kramer BS
    JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of prostate cancer in Sicily: results of a multicenter case-findings protocol.
    Aragona F; Pepe P; Motta M; Saita A; Raciti G; La Rosa P; Nicolosi D; Dammino A; Minaldi G; Rizza G; Azzarello G; Aragona C; Rotondo S; Orestano L; Serrao A; Amico F; Dibenedetto G; Cosentino V; Iurato C; Raffino S; Gulletta M; Calarco A; Paola Q; Barbera M; Gulino V; Capizzi G; Orestano F
    Eur Urol; 2005 May; 47(5):569-74. PubMed ID: 15826745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia.
    Marley GM; Miller MC; Kattan MW; Zhao G; Patton KP; Vessella RL; Wright GL; Schellhammer PF; Veltri RW
    Urology; 1996 Dec; 48(6A Suppl):16-22. PubMed ID: 8973695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of prostate cancer in the mediterranean population of Croatia--a thirty-three year retrospective study.
    Spanjol J; Maricić A; Cicvarić T; Valencić M; Oguić R; Tadin T; Fuckar D; Bobinac M
    Coll Antropol; 2007 Mar; 31(1):235-9. PubMed ID: 17598407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of cancer of the prostate diagnosis and management in Nigeria: the experience in a Nigerian tertiary hospital.
    Ajape AA; Ibrahim KO; Fakeye JA; Abiola OO
    Ann Afr Med; 2010; 9(3):113-7. PubMed ID: 20710099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study.
    Møller MH; Kristiansen IS; Beisland C; Rørvik J; Støvring H
    BJU Int; 2016 Oct; 118(4):547-55. PubMed ID: 26497872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.
    Ranasinghe WK; Kim SP; Lawrentschuk N; Sengupta S; Hounsome L; Barber J; Jones R; Davis P; Bolton D; Persad R
    BJU Int; 2014 Jan; 113(1):77-83. PubMed ID: 24053128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observational survey on variations of prostate cancer incidence by stage in the Nord-Pas-de-Calais region between 1998 and 2004].
    Flamand V; Zini L; Salleron J; Fantoni JC; Biserte J; Villers A
    Prog Urol; 2008 Jan; 18(1):53-9. PubMed ID: 18342157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Crude rate increase of prostate cancer incidence in our setting].
    Caballero Alcántara J; Marchal Escalona C; Padilla León M; Rodrigo Fernández I
    Actas Urol Esp; 2001 Oct; 25(9):624-7. PubMed ID: 11765545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass screening of prostate cancer in Changchun City of China.
    Li X; Tsuji I; Kuwahara M; Zhang H; Wang H; Zhang L; Ji G; Zhao X
    Int Urol Nephrol; 2004; 36(4):541-8. PubMed ID: 15787333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer incidence in Turkey: an epidemiological study.
    Zorlu F; Zorlu R; Divrik RT; Eser S; Yorukoglu K
    Asian Pac J Cancer Prev; 2014; 15(21):9125-30. PubMed ID: 25422189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.